Sensei Biotherapeutics Q2 EPS $(0.31) Beats $(0.33) Estimate
Portfolio Pulse from Benzinga Newsdesk
Sensei Biotherapeutics reported Q2 losses of $(0.31) per share, beating the analyst consensus estimate of $(0.33) by 6.06%. This represents an 8.82% improvement over the same period last year.
August 04, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Sensei Biotherapeutics reported better than expected Q2 earnings, with losses per share of $(0.31), beating estimates by 6.06%.
Sensei Biotherapeutics reported a smaller loss than expected for Q2, which is generally seen as a positive sign by investors. This could lead to increased investor confidence and a potential short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100